Abstract
The Cruciferae (also known as the Brassicaceae) are the family of plants that include the various familiar members of the species Brassica oleracea (e.g., broccoli, cabbage, cauliflower, kale, Brussels sprouts) as well as many other plants that are widely consumed in various parts of the world. Forage and root brassicas are widely used as winter feeds for cattle and sheep. A striking and characteristic chemical property of cruciferous plants is their high content of glucosinolates (more than 120 types), which often approaches 1% or more of their dry weight. The interest devoted to this group of natural products is caused by the appreciable biological effects of both the intact glucosinolates (GSLs) and especially the complex group of glucosinolate transformation products produced in non-enzymatic and enzymatic reactions. Depending on the concentration and structural types of these compounds, their biological effects can be toxic, antinutritional or beneficial to health. Most serious economic problems in livestock seem to result from rapeseed meal; arising from GSLs or their breakdown products. In contrast, GSLs and their isothiocyanate (ITC) hydrolysis products are reportedly well-known protectors against carcinogenesis. GSLs play further protective and evolutionarily important roles in plants. These include allelopathy (suppression of growth of neighboring plants), specific positive and negative feeding cues for some insects and broad antibiotic properties including nematocidal, antimicrobial, antifungal, antiprotozoal and insecticidal activities. The controversy in the referred actions contributed to crucifers phytochemicals has been exclusively discussed.
Keywords: Brassicaceae, Cruciferae, glucosinolates, GSLs, isothiocyanate, ITC, phytochemicals, toxic, cancer chemoprotection
Mini-Reviews in Medicinal Chemistry
Title: Cruciferous Plants: Phytochemical Toxicity Versus Cancer Chemoprotection
Volume: 9 Issue: 13
Author(s): Mohamed E. Assayed and A. M. Abd El-Aty
Affiliation:
Keywords: Brassicaceae, Cruciferae, glucosinolates, GSLs, isothiocyanate, ITC, phytochemicals, toxic, cancer chemoprotection
Abstract: The Cruciferae (also known as the Brassicaceae) are the family of plants that include the various familiar members of the species Brassica oleracea (e.g., broccoli, cabbage, cauliflower, kale, Brussels sprouts) as well as many other plants that are widely consumed in various parts of the world. Forage and root brassicas are widely used as winter feeds for cattle and sheep. A striking and characteristic chemical property of cruciferous plants is their high content of glucosinolates (more than 120 types), which often approaches 1% or more of their dry weight. The interest devoted to this group of natural products is caused by the appreciable biological effects of both the intact glucosinolates (GSLs) and especially the complex group of glucosinolate transformation products produced in non-enzymatic and enzymatic reactions. Depending on the concentration and structural types of these compounds, their biological effects can be toxic, antinutritional or beneficial to health. Most serious economic problems in livestock seem to result from rapeseed meal; arising from GSLs or their breakdown products. In contrast, GSLs and their isothiocyanate (ITC) hydrolysis products are reportedly well-known protectors against carcinogenesis. GSLs play further protective and evolutionarily important roles in plants. These include allelopathy (suppression of growth of neighboring plants), specific positive and negative feeding cues for some insects and broad antibiotic properties including nematocidal, antimicrobial, antifungal, antiprotozoal and insecticidal activities. The controversy in the referred actions contributed to crucifers phytochemicals has been exclusively discussed.
Export Options
About this article
Cite this article as:
Assayed E. Mohamed and Abd El-Aty M. A., Cruciferous Plants: Phytochemical Toxicity Versus Cancer Chemoprotection, Mini-Reviews in Medicinal Chemistry 2009; 9 (13) . https://dx.doi.org/10.2174/138955709790361511
DOI https://dx.doi.org/10.2174/138955709790361511 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacotherpy and Alzheimer’s Disease: The M-Drugs (Melatonin, Minocycline, Modafinil, and Memantine) Approach
Current Pharmaceutical Design From Peptides to Small Molecules: An Intriguing but Intricated Way to New Drugs
Current Medicinal Chemistry Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
Current Pharmaceutical Design Clinical Experiment of Mutant Herpes Simplex Virus HF10 Therapy for Cancer
Current Cancer Drug Targets A Review on Medical Image Registration as an Optimization Problem
Current Medical Imaging Application of Transcranial Color-Coded Duplex Sonography in Stroke Diagnosis
Current Medical Imaging Neurosteroids and Hepatic Encephalopathy: An Update on Possible Pathophysiologic Mechanisms
Current Molecular Pharmacology Colchicine in Neurosurgery
Current Pharmaceutical Design 4-Aminocyclopentane-1,3-diols as Platforms for Diversity: Synthesis of Anandamide Analogs
Medicinal Chemistry Context-dependent Action of Transforming Growth Factor β Family Members on Normal and Cancer Stem Cells
Current Pharmaceutical Design A Role of Immunotherapy in Metastatic Malignant Melanoma
Central Nervous System Agents in Medicinal Chemistry Voltage-Dependent Potassium Channels Kv1.3 and Kv1.5 in Human Cancer
Current Cancer Drug Targets The Contrasting Roles of NKT Cells in Tumor Immunity
Current Molecular Medicine Apoptosis in Drug Response
Current Pharmacogenomics Mast Cells and Basophils: Trojan Horses of Conventional Lin- Stem/Progenitor Cell Isolates
Current Pharmaceutical Design Angiogenesis Inhibitors: Implications for Combination with Conventional Therapies
Current Pharmaceutical Design Recent Clinical Experience with Oncolytic Viruses
Current Pharmaceutical Biotechnology STAT3 as a Central Regulator of Tumor Metastases
Current Molecular Medicine Synthesis and Characterization of Two New Thiophene Acetyl Salicylic Acid Esters and their ortho- and para-effect on Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry Mutant Epidermal Growth Factor Receptors as Targets for Cancer Therapy
Current Cancer Drug Targets